Developing a Canadian prescribing practices network, Table 1

Table 1: Examples of stakeholders in a national prescribing practices network*

Publicly funded
Adverse drug reaction centres (national and regional)

Educators

Key information sources (e.g., Cochrane Collaboration)

National Pharmaceutical Strategy

Outcomes data analyses groups (e.g., CIHI, ICES, CCOHTA)

Prescribers

Provincial drug plans

Researchers in therapeutics

Privately funded
Claims managers (e.g., Shared Health, Eclipse) and employee-benefit managers

Contract research organizations (e.g., INNOVUS, LAB)

Drug utilization review companies (e.g., IMS Canada, Brogan Consulting)

Pharmaceutical industry (e.g., PMAC, CDMA)

Pharmacies

Professional licensing bodies

Professional societies

Third-party insurance plans (e.g., Green Shield, Blue Cross)

Publicly and privately funded
Consumer advocate groups

Informatics experts

Research granting agencies

Therapeutics research networks (proposed, e.g., HENCE)

* CIHI = Canadian Institute for Health Information, ICES = Institute for Clinical Evaluative Sciences in Ontario, CCOHTA = Canadian Coordinating Office for Health Technology Assessment, PMAC = Pharmaceutical Manufacturers Association of Canada, CDMA = Canadian Drug Manufacturers Association, HENCE = Health Network of Centres of Excellence.

[Return to text]